Dendreon analyst: There's not 'much of a future' for the company or its drug
November 11, 2014 at 16:16 PM EST
Seattle biotech Dendreon Corp.'s bankruptcy filing yesterday is raising questions about the future of that company and others that produce pricey immunotherapy drugs for the treatment of cancer...